Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

NCT00321061 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: VRC-HIVDNA016-00, VRC-HIVADV014-00

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)